Skip to main navigation Skip to search Skip to main content

Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination

  • Hannah Kapell
  • , Luca Fazio
  • , Julia Dyckow
  • , Sophia Schwarz
  • , Andrés Cruz-Herranz
  • , Christina Mayer
  • , Joaquin Campos
  • , Elisa D’Este
  • , Wiebke Möbius
  • , Christian Cordano
  • , Anne Katrin Pröbstel
  • , Marjan Gharagozloo
  • , Amel Zulji
  • , Venu Narayanan Naik
  • , Anna Delank
  • , Manuela Cerina
  • , Thomas Müntefering
  • , Celia Lerma-Martin
  • , Jana K. Sonner
  • , Jung Hyung Sin
  • Paul Disse, Nicole Rychlik, Khalida Sabeur, Manideep Chavali, Rajneesh Srivastava, Matthias Heidenreich, Kathryn C. Fitzgerald, Guiscard Seebohm, Christine Stadelmann, Bernhard Hemmer, Michael Platten, Thomas J. Jentsch, Maren Engelhardt, Thomas Budde, Klaus Armin Nave, Peter A. Calabresi, Manuel A. Friese, Ari J. Green, Claudio Acuna, David H. Rowitch, Sven G. Meuth, Lucas Schirmer
  • Heidelberg University
  • Universitätsklinikum Münster
  • Heinrich-Heine-University
  • University of California San Francisco
  • University Medical Center Hamburg-Eppendorf
  • Heidelberg University
  • Max-Planck-Institut für Medizinische Forschung
  • Max Planck Institute of Experimental Medicine
  • Georg August Universität Göttingen
  • University Hospital Basel
  • Johns Hopkins School of Medicine
  • University of Münster
  • University of California San Francisco
  • Technical University of Munich
  • Max Delbrück Center for Molecular Medicine
  • University Medical Center
  • Munich Cluster for Systems Neurology (SyNergy)
  • German Cancer Research Center
  • Interdisciplinary Center for Neurosciences (IZN)
  • Charité – Universitätsmedizin Berlin
  • Johannes Kepler University Linz
  • Jeffrey Cheah Biomedical Centre
  • Department of Paediatrics

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Multiple sclerosis (MS) is a progressive inflammatory demyelinating disease of the CNS. Increasing evidence suggests that vulnerable neurons in MS exhibit fatal metabolic exhaustion over time, a phenomenon hypothesized to be caused by chronic hyperexcitability. Axonal Kv7 (outward-rectifying) and oligodendroglial Kir4.1 (inward-rectifying) potassium channels have important roles in regulating neuronal excitability at and around the nodes of Ranvier. Here, we studied the spatial and functional relationship between neuronal Kv7 and oligodendroglial Kir4.1 channels and assessed the transcriptional and functional signatures of cortical and retinal projection neurons under physiological and inflammatory demyelinating conditions. We found that both channels became dysregulated in MS and experimental autoimmune encephalomyelitis (EAE), with Kir4.1 channels being chronically downregulated and Kv7 channel subunits being transiently upregulated during inflammatory demyelination. Further, we observed that pharmacological Kv7 channel opening with retigabine reduced neuronal hyperexcitability in human and EAE neurons, improved clinical EAE signs, and rescued neuronal pathology in oligodendrocyte–Kir4.1–deficient (OL-Kir4.1–deficient) mice. In summary, our findings indicate that neuron-OL compensatory interactions promoted resilience through Kv7 and Kir4.1 channels and identify pharmacological activation of nodal Kv7 channels as a neuroprotective strategy against inflammatory demyelination.

Original languageEnglish
Article numbere164223
JournalJournal of Clinical Investigation
Volume133
Issue number7
DOIs
StatePublished - 3 Apr 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination'. Together they form a unique fingerprint.

Cite this